Skip to content
Matica Biotechnology Manufacturing Breakthroughs
  • About
    • Who We Are
    • Leadership
  • Services
    • Cell Line and Vector Development
      • MatiMax™ Platform
    • Process Development
    • Assay Development
    • GMP Production
    • Quality
  • News & Events
    • Newsroom
    • Events
  • Resources
  • Careers
  • Contact Us
  • About
    • Who We Are
    • Leadership
  • Services
    • Cell Line and Vector Development
      • MatiMax™ Platform
    • Process Development
    • Assay Development
    • GMP Production
    • Quality
  • News & Events
    • Newsroom
    • Events
  • Resources
  • Careers
  • Contact Us

2025

News

Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi’s Project Toward IND

November 3, 2025

News

Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy

October 6, 2025

News

Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company

September 15, 2025

News

Matica Biotechnology and Cirsium Biosciences Announce AAV Manufacturing Collaboration

September 8, 2025

News

Matica Biotechnology and Texas A&M’s NCTM Form Strategic Partnership to Deliver End-to-End Support for Cell and Gene Therapy Innovators

May 5, 2025

News

College Station CDMO partners with nonprofit to develop treatments for rare diseases

March 5, 2025

News

Child’s Cure Genetic Research collaborates with Matica Bio to Drive Innovation in Pediatric Rare Disease Therapies

January 7, 2025

Get in Touch

When Bringing Your Therapy to Market Is Everything,

Make it happen with Matica Bio.

Get Started

© 2025 Matica Biotechnology. All Rights Reserved.

LinkedIn
  • Site Map
  • Privacy Policy
  • Contact Us
How can we help you?